Strides Pharma Science Ltd Quarterly Results

Gross Sales

1,190.39

1,153.67

1,166.93

1,087.51

1,043.5

Excise Duty

0

0

0

0

0

Net Sales

1,190.39

1,153.67

1,166.93

1,087.51

1,043.5

Other Operating Income

0

0

0

0

0

Other Income

15.11

6.57

28.41

12.72

-13.55

Total Income

1,205.5

1,160.24

1,195.35

1,100.22

1,029.96

Total Expenditure

999.94

945.78

986.86

886.07

887.96

PBIDT

205.56

214.45

208.49

214.16

142

Interest

50.32

52.18

73.82

80.39

71.1

PBDT

155.24

162.27

134.66

133.77

70.9

Depreciation

48.86

48.42

48.45

48.59

47.94

Minority Interest Before NP

0

0

0

0

0

Tax

4.57

11.66

15.15

19.12

9.37

Deferred Tax

16.19

12.14

-1.21

-2.26

3.15

Reported Profit After Tax

85.62

90.04

72.27

68.31

10.44

Minority Interest After NP

3.42

2.09

0.43

-1.89

-7.73

Net Profit after Minority Interest

82.19

87.95

71.84

70.2

18.18

Extra-ordinary Items

-22.07

-1.92

-3.19

-2.9

-10.26

Adjusted Profit After Extra-ordinary item

104.26

89.87

75.03

73.1

28.44

EPS (Unit Curr.)

8.92

9.56

7.81

7.64

1.98

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

92.16

92.16

91.96

91.9

91.9

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

17.26

18.58

17.86

19.69

13.6

PBDTM(%)

13.04

14.06

11.53

12.3

6.79

PATM(%)

7.19

7.8

6.19

6.28

1